Background: The intricate relationship between type 2 diabetes mellitus (T2DM) and Alzheimer’s disease (AD) suggests that insulin is involved in modulating AD-related proteins. This evidence concerns the gene INS and early-onset autosomal dominant Alzheimer disease.